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Rats(r) with secondary hyperparathyroidism were studied to deﬁne the relationship between vitamin D metabolites and rPTH
levels measured by 3 diﬀerent rat ELISAs. Controls and renal failure (RF) rats were on a normal diet, while 2 groups on a low-
calcium (-Ca) or a vitamin D-deﬁcient (-D) diet. RF was induced surgically. Mild RF rats had normal calcium and 25(OH)D but
reduced 1,25(OH)2Dl e v e l s( P<. 001) with a 2.5-fold increased in rPTH (P<. 001). Severe RF rats and those on a -Ca or -D
diet had reduced calcium (P<. 01) and 25(OH)D levels (P<. 05), with rPTH increased by 2 (-Ca diet; P<. 05), 4 (-D diet;
P<. 001), and 20-folds (RF; P<. 001) while 1,25(OH)2D was high (-Ca diet: P<. 001) or low (-D diet, RF: P<. 001). 25(OH)D
and 1,25(OH)2D were positively and negatively related on the -Ca and -D diets, respectively. rPTH molecular forms behaved as
expected in RF and on -Ca diet, but not on -D diet with more C-rPTH fragments when less were expected. This may be related to
the short-time course of this study compared to prior studies.
1.Introduction
The behavior of circulating PTH molecular forms during
the development of secondary hyperparathyroidism (sHPT)
is related to the cause of sHPT. In experimental calcium
and vitamin D-deﬁcient dogs, ionized calcium remains
unchanged until 1,25(OH)2D starts to decline after an
initial increment. This behavior was attributed to 25(OH)D
levels dipping below 20nmol/L [1]. Furthermore, as sHPT
progresses, basal, stimulated, and nonsuppressible Intact
(I) PTH increases more than carboxyl-terminal (C) PTH
levels, indicating a shift in PTH secretion toward PTH(1-
84) [1]. When these dogs were replenished with vita-
min D, ionized calcium and 25(OH)D normalized rapidly
while 1,25(OH)2D initially reached supraphysiological val-
ues which progressively regressed to normal with time [2].
While I-PTH normalized to prior vitamin D deﬁciency
values, C-PTH remained elevated with a 2-fold rise in
the C-PTH/I-PTH ratio, indicating adaptation to increased
parathyroid tissue mass through oversecretion of C-PTH
fragments [2]. The latter ﬁnding was further sustained by
low-dose 1,25(OH)2D therapy in normal dogs which, with-
out augmenting calcium concentration, caused a decrease
in I-PTH but not C-PTH secretion, heightening the C-
PTH/I-PTH ratio at all calcium concentrations [3]. This
tight regulation of C-PTH fragments suggested possible
biological eﬀects of these fragments which were eventually
demonstrated both in vivo [4–6] and in vitro [7]. C-
PTH fragments exert biological eﬀects which are opposite
to those of PTH(1-84) or PTH(1-34) on the PTH/PTHrP
t y p eIr e c e p t o rb ya c t i n go nad i ﬀerent receptor [4–7]. The
evolution of circulating PTH molecular forms during sHPT
due to renal failure (RF) is diﬀerent, mainly because C-PTH
fragments are cleared by the kidneys [8–10]. Hypocalcemia
usually develops when the glomerular ﬁltration rate (GFR)
fallsbelow 30ml/min/1.73m2 inrelation to low 1,25(OH)2D2 International Journal of Endocrinology
and high phosphate levels [10]. The elevation of I- and C-
PTH levels is rapid and already evident in stage 2 disease
(GFR > 60ml/min/1.73m2) with more rapid progression
of C-PTH than I-PTH values as the GFR decreases [10].
RF patients with severe sHPT manifest a lower C-PTH/I-
PTH ratio than patients with mild sHPT, indicating higher
PTH(1-84) production relative to C-PTH fragments in
severe sHPT [8]. 25(OH)D levels also decrease as GFR
decreases [11–15] but the mecanisms involved are unclear.
Rat(r) PTH ELISAs developed by Scantibodies Laboratory
Inc. were used to study the relationship between rPTH
molecular forms, 25(OH)D and 1,25(OH)2Dc o n c e n t r a -
tions, during sHPT ascribed to a low-calcium diet (-Ca diet),
a vitamin D-deﬁcient diet (-D diet), or RF. With some minor
diﬀerences, results indicate a similar behavior of circulating
PTH molecular forms in various species.
2.MaterialsandMethods
2.1. Experimental Methods
2.1.1. Products. All special diets were purchased from Harlan
Teklad (Madison, WI, USA). All hPTH and rPTH peptides
were obtained from BACHEM (Torrance, CA, USA), some
fromtheregularcatalogandothersnewlysynthesizedforthis
project.
2.1.2. Biochemistry. Ionized calcium (Ca2+) was quantitated
by Ca2+-speciﬁc electrode (Rapid Lab Model 348, Bayer
Diagnostic, Toronto, ON, Canada). Total calcium, phos-
phate, albumin, creatinine, and alkaline phosphatase were
measured by colorimetric methods adapted to multianalyzer
evaluation. For other measurements, samples remained at
room temperature for a maximum of 30 minutes and were
transferred and centrifuged at 4◦C within 2 hours, aliquoted
a n ds t o r e da t−80◦C until assayed. Serum was used for
all assays. 25(OH)D was studied by a radioimmunoassay
from IDS Inc. (Fountain Hills, AZ, USA). 1,25(OH)2Dw a s
assessed by enzyme-linked immune-sorbent assay (ELISA)
from ALPCO Diagnostics (Salem, NH, USA). rPTH was
investigated by 3 diﬀerent ELISAs from Scantibodies Labora-
tory Inc. (Santee, CA, USA). The characteristics of the three
rPTH ELISAs have been described previously [16].
2.1.3. HPLC Analysis. Sera were pooled from all animals in
each group for HPLC analysis of circulating rPTH molecular
forms. Each pool of sera was ﬁrst extracted with Waters Sep-
Pak Plus C-18 cartridges, as described by Bennett et al. [17].
One C-18 cartridge was employed for each 3ml of serum.
Samplesw e r eel u t edfr o mthecartridgewith5mlo f800ml/L
acetonitrile in 1g/L triﬂuoroacetic acid. Acetonitrile was
evaporated from the eluate with nitrogen, and the residual
volume was freeze-dried and reconstituted in 0.5ml of 1g/L
trioﬂuoroacetic acid for HPLC analysis. Each 0.5mL sample
was loaded on a Waters C18 µBondapak analytical column
(300 × 3.9mm (i.d.)) and eluted with a noncontinuous
linear gradient of acetonitrile in 1g/L triﬂuoroacetic acid.
The gradient, ranging from 19 to 33.5% in 15 minutes
and from 33.5 to 35.2% in 45 minutes, was delivered at
1.0mL/min with an Agilent 1100 series solvent delivery
system. 1.0mL fractions were evaporated, freeze-dried, and
reconstituted to 1mL with 7g/L BSA in water; adequate
volumes were then measured in each rPTH assay. Control
experiments were performed with rPTH(1-84) calibrator
added to hypoparathyroid rat serum to ensure that PTH
degradation did not occur during the various procedures. A
single peak of immunoreactivity coeluting with rPTH(1-84)
was detected by the 3rPTH assays. Immunoreactive rPTH
recovery by rPTH assays through all these procedures was
better than 80% for all HPLC runs, based on comparison
of the original pool rPTH value with the sum of rPTH
immunoreactivity across all HPLC fractions.
2.1.4.ExperimentalAnimals. MaleSprague-Dawleyratswere
purchased at 76 to 100g from Charles-River Canada (St-
Constant QC, Canada) and maintained in cages according
to the guidelines of the Canadian Council on Animal Care.
T h r e eg r o u p s( 1c o n t r o la n d2r e n a lf a i l u r e( R F )g r o u p s )
were maintained on a normal calcium and vitamin D
diet as soon as they were delivered to our centre. Two
groups were fed either a low-calcium (0.1% calcium 0.3%
phosphorus) vitamin D-suﬃcient or vitamin D-deﬁcient
calciumsuﬃcient(0.5%calciumand0.3%phosphorus)diet.
All groups received their respective diets for 33 days. RF
was induced by 5/6 nephrectomy under general anesthesia
as 2 consecutive procedures, 2/3 nephrectomy of the left
kidney on the ﬁrst day, followed by right total nephrectomy
6 days later. Eventually, these rats were divided into 2 groups
according to a serum creatinine value below or above
150µmol/L. They were sacriﬁced after 33 days of diet or 33
daysafterthesecondsurgery.Inallcases,theyweresacriﬁced
under general anesthesia by exsanguination through the
abdominal vena cava.
2.1.5. Statistical Analysis. The results are means ± SD.
Diﬀerences between groups were analyzed by Kruskal-Wallis
ANOVA, followed by Dunn’s multiple comparison test when
the distribution of values was not Gaussian or by ANOVA,
followed by Dunnett’s multiple comparison test when the
distributionwasGaussian.-Cadietand-Ddietratsandthe2
RFgroupswerecomparedbyunpairedT-testwithorwithout
Welch correction. Standard methods were used for linear
regression between various biochemical parameters. HPLC
proﬁleswereevaluatedplanimetricallybyOrigin8.5software
(OriginLab Corporation, Northampton, MA, USA). HPLC
proﬁles were corrected to 100% recovery and to the mean
pool value expressed in pmol/L.
3. Results
Figure 1 illustrates the relationship between rPTH assays
epitopes and detected circulating rPTH molecular forms.
TheWhole(W)rPTHassayhasa2–7epitopeandreactswith
rPTH(1-84) and N-rPTH, a posttranslationaly modiﬁed
form of rPTH(1-84) on circulating rPTH HPLC proﬁles.
The Total (T) rPTH assay has a 22–34 epitope and reacts
with rPTH(1-84), N-rPTH, and non-(1-84) rPTH or large
carboxyl-terminal (C) fragments with a partially preservedInternational Journal of Endocrinology 3
Table 1: Evolution of biochemical parameters with various diets and partial nephrectomy.
Parameters Normal calcium (0.5%) Low calcium (0.1%) Vitamin D deﬁciency Moderate renal failure Severe renal failure
N 10 12 13 7 7
Weight (g) 405 ±31 379 ±35 390 ±30 374 ±45 278 ±64
∗∗∗,••
Ca++ (mmol/L) 1.30 ±0.02 1.28 ±0.03 1.24 ±0.02
∗∗,++ 1.25 ±0.03 1.15 ±0.08
∗∗∗,•
Cat (mmol/L) 2.58 ±0.06 2.42 ±0.10
∗∗ 2.42 ±0.09
∗∗ 2.56 ±0.07 2.47 ±0.20
PO4 (mmol/L) 3.01 ±0.27 3.15 ±0.11 2.86 ± 0.27++ 2.44 ±0.27
∗∗ 3.10 ±0.57
•
Creatinine (µmol/L) 30 ±23 1 ±43 4 ±7 111 ±9∗∗ 252 ±84
∗∗∗,••
Alkaline phosphatase (U/L) 403 ±138 939 ±372
∗∗∗ 351 ±177+++ 259 ±56 174 ±62
∗∗∗,•
Total protein (g/L) 52 ±25 4 ±25 5 ±25 1 ±24 5 ±6•
Albumin (g/L) 23 ±12 3 ±12 4 ± 1+ 21 ±1∗∗ 20 ±1∗∗∗,•
25(OH)D (nmol/L) 97 ±18 38 ±3∗ 18 ±2∗∗∗,+++ 90 ±32 39 ±11
∗,••
1,25(OH)2D (pmol/L) 129 ±51 565 ±86
∗∗∗ 58 ±18
∗∗∗,+++ 46 ±10
∗∗∗ 38 ±8∗∗∗
Results are means ± SD. All group statistics were assessed by ANOVA, followed by Dunnett’s multiple comparison test (Kruskal-Wallis ANOVA, followed by
Dunn’s comparison test for creatinine, total protein, and 25(OH)D). ∗P<. 05; ∗∗P<. 01; ∗∗∗P<. 001. Unpaired T-test with or without Welch correction:
Low-calcium versus vitamin D-deﬁcient diet: +P<. 05; ++P<. 01; +++P<. 001. Moderate versus severe renal failure: •P<. 05; ••P<. 01; •••P<. 001.
Epitopes
W r-PTH T r-PTH
N-rPTH
C-rPTH fragments
C r-PTH
22 40 60
34
34
34
34
34
84
84
84
84 37
1
1 17
47
2
10 15
Circulating rPTH
molecular forms
43
7
rPTH(1-84)
Non(1-84) rPTH
Figure 1: Relationship between rPTH assays epitopes and circulating rPTH molecular forms detected. N-PTH = amino-terminal rPTH, a
posttranslationally modiﬁed form of rPTH(1-84) on serine 17. Non(1-84) large C-rPTH fragments have a partially preserved N-structure
while smaller C-rPTH fragments miss that structure (18).
N-structure, the prototype of which is rPTH(7-84). The C-
rPTH assay has a 40–60 epitope and reacts with rPTH(1-
84), N-rPTH, non-(1-84) rPTH, but mainly with smaller C-
rPTH fragments missing an N-structure which represent the
majorityofcirculatingrPTH.TheC-rPTHassayhasagreater
aﬃnity for these fragments than for the other circulating
PTH molecular forms.
Compared to the controls, rats on a -Ca diet (Tables 1
and 2) had decreased total calcium concentration (P<. 01),
2-fold increased alkaline phosphatase activity (P<. 001),
low 25(OH)D (P<. 05) but elevated 1,25(OH)2Dl e v e l s
(P<. 001), and a greater increment of C-rPTH (P<. 001)
than W-rPTH (P<. 05). C-rPTH/W-rPTH and C-rPTH/T-
rPTH ratios tended to rise without reaching signiﬁcance.
A positive correlation was observed between 25(OH)D and
1,25(OH)2Dl e v e l s( P<. 05) on the -Ca diet (Figure 2(a)).
Rats on the -D diet (Tables 1 and 2) had low ionized and
total calcium values (P<. 01), low 25(OH)D (P<. 001)
and 1,25(OH)2D( P<. 001), a 2- to 3-fold elevation of rPTH
(P<. 001), and a signiﬁcant increase in the C-rPTH/T-rPTH
ratio (P<. 05). Their 25(OH)D and 1,25(OH)2Dl e v e l sw e r e
lower (P<. 001) and their rPTH levels were higher (P<. 01)
than those in rats on a -Ca diet. A negative correlation was
noted between 25(OH)D and 1,25(OH)2Dl e v e l s( P<. 05)
onthe-Ddiet(Figure 2(b)).RatswithmoderateRF(Tables1
and 2) remained normocalcemic with a 3-fold rise in
serum creatinine, maintained normal 25(OH)D with low
1,25(OH)2Dl e v e l s( P<. 001), and presented 2- to 3-fold
higher W-rPTH (P<. 001) and C-rPTH (P<. 001) levels.
Their T/W-rPTH was signiﬁcantly decreased (P<. 05).
Finally, rats with severe RF (Tables 1 and 2)h a dl o wb o d y
weight (P<. 01), low ionized calcium (P<. 001), an 8-
fold increase in serum creatinine (P<. 001), diminished
alkaline phosphatase activity (P<. 001), reduced 25(OH)D
(P<. 05) and 1,25(OH)2Dl e v e l s( P<. 001), and a 20- to
35-fold elevation of W (P<. 001), T (P<. 001), and C-rPTH
(P<. 001) with diminution of the T-rPTH/W-rPTH ratio
(P<. 001) and a heightened C-rPTH/T-rPTH ratio (P<
.001). Their 25(OH)D levels were lower (P<. 01) and rPTH
levels (P<. 05) were much higher than those in rats with
moderate RF. A negative correlation was apparent between
ionized calcium, 25(OH)D and creatinine levels (P<. 05),
with a positive correlation between phosphate, C-rPTH
levels, and creatinine concentrations (P<. 05) (Figure 3). A
positive correlation was found between ionized calcium and
25(OH)D levels (P<. 05) and negative correlations between
25(OH)D and phosphate or W or C-rPTH levels (P<. 05)
(Figure 3).4 International Journal of Endocrinology
Table 2: Evolution of rPTH and rPTH ratio with various diets and partial nephrectomy.
Parameters Normal calcium (0.5%) Low calcium (0.1%) Vitamin D deﬁciency Moderate renal failure Severe renal failure
N1 0 1 2 1 3 7 7
W-rTH (pmol/L) 4.0 ± 1.27 .7 ±3.9
∗ 15.0 ±7.6
∗∗∗,++ 11.6 ±4.9
∗∗∗ 114 ±72.6∗∗∗,••
T-rPTH (pmol/L) 5.9 ± 1.41 1 .1 ±5.12 0 .8 ±9.9
∗∗∗,++ 13.4 ±6.9 116.1 ± 79.1∗∗∗,•
C-rPTH (pmol/L) 7.3 ± 2.61 7 .4 ±8.9
∗∗∗ 37.2 ±15.8
∗∗∗,+++ 23.1 ±15.0
∗∗∗ 268.4 ±121.4
∗∗∗,••
T/W-rPTH ratio 1.50 ± 0.13 1.48 ±0.12 1.41 ±0.10 1.12 ±0.38
∗ 0.97 ±0.13
∗∗∗
C/W-rPTH ratio 1.85 ± 0.46 2.35 ±0.47 2.66 ±0.70 2.02 ±0.84 2.73 ±1.51
C/T-rPTH ratio 1.24 ± 0.35 1.58 ±0.29 1.88 ±0.49
∗ 2.24 ±1.65 2.96 ±2.07
∗∗∗
Results are means + SD. All group statistics were assessed by ANOVA, followed by Dunnett’s multiple comparison test (Kruskal-Wallis ANOVA followed by
Dunn’s comparison test for rTotal-PTH, rTotal/rWhole ratio, rCarboxyl/rTotal ratio) ∗P<. 05; ∗∗P<. 01; ∗∗∗P<. 001. Unpaired T-test with or without
Welch correction: low-calcium versus vitamin D-deﬁcient diet: +P<. 05; ++P<. 01; +++P<. 001. Moderate versus severe renal failure: •P<. 05; ••P<. 01;
•••P<. 001.
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Figure 2: Relationship between 25(OH)D and 1,25(OH)2D levels in rats on the calcium-deﬁcient diet (a) and the vitamin D-deﬁcient diet
(b).
Figure 4 and Table 3 summarize the results of high-
pressure liquid chromatography (HPLC) proﬁle analysis in
the various groups. Rats on a normal calcium diet, like the
other groups, disclosed 4 types of rPTH molecular forms
in the circulation: rPTH(1-84) (regions 42 to 46), N-rPTH
(regions 38 to 42), a posttranslationally modiﬁed form of
rPTH(1-84), non-(1-84) rPTH fragments (regions 25–32)
or large C-PTH fragments with a partially preserved N-
structure, and C-rPTH fragments (regions 8 to 20) which
lacked an N-structure. rPTH(1-84) was identiﬁed by all
3 rPTH assays, as was N-rPTH. N-rPTH tended to be
over-evaluated by C-rPTH assay in relation to the use of
a rPTH(39-84) standard which was more immunoreactive
on a molar basis than the rPTH(1-84) standard. Non-(1-
84) PTH fragments were mainly detected by T-rPTH assay,
and smaller C-rPTH fragments exclusively by C-rPTH assay.
With W-rPTH assay, rPTH(1-84) represented more than
90% of immunoreactivity in the diet groups, but only 66%
in RF rats relative to N-rPTH accumulation. With T-rPTH
assay, all groups had lower % rPTH(1-84) than the controls.
This was attributed to more non-(1-84) rPTH fragments on
the-Caand-DdietsandtomoreN-rPTHinRF.Finally,with
C-rPTH assay, rPTH(1-84) represented 46 and 39% of rPTH
in control and -Ca diet rats and 52% in -D diet rats. These
percentages decreased to 29 and 27% in moderate and severe
RF rats, respectively, in relation to N-rPTH accumulation
in moderate RF and C-rPTH fragments in severe RF. In
each case, C-rPTH fragments explained 34 to 57% of non-
rPTH(1-84)immunoreactivity withthehighest%inRFrats.
4. Discussion
The 3 rPTH assays used in this study were demonstrated to
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Figure 3: Relationship between creatinine or 25(OH)D and calcium, phosphate, and rPTH levels in rats with moderate (•)o rs e v e r e( )
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Figure 4: HPLC proﬁles of circulating rPTH molecular forms analyzed in Whole (–), Total (----), and Carboxyl-rPTH (-.-.-.-) assays in
rats on a normal calcium diet (a), a low-calcium diet (b), a vitamin D-deﬁcient diet (c), or with moderate (d) or severe (e) renal failure. A
single HPLC proﬁle obtained with a pool of serum from all rats in a given group is illustrated.
in humans [18–21]a n dd o g s[ 3]. Thus, rPTH(1-84), N-
rPTH, non-(1-84) rPTH, and C-rPTH fragments were noted
on rat HPLC proﬁles. Diﬀerences from hPTH HPLC proﬁles
may include more rPTH(1-84) and less C-rPTH fragments
in rats compared to humans in the basal state [20].
These assays were tested to investigate the behavior of
circulating rPTH molecular forms in sHPT induced by a
-Ca diet, a -D diet, and RF induced by 5/6 nephrectomy.
With the -Ca diet, we observed decreased total calcium
levels, increased alkaline phosphatase activity, low 25(OH)D
with very high 1,25(OH)2D concentrations, and elevated
W- and C-rPTH levels. A positive correlation was seen
between 25(OH)D and 1,25(OH)2D levels. rPTH ratios
remained unchanged. Diminished intestinal absorption of
calcium due to very low calcium supply, even if 1,25(OH)2D
concentrations were augmented, best explained the hypocal-
cemia [22, 23]. The high alkaline phosphatase activity was
attributed to a defective mineralization rate in the face of
elevated 1,25(OH)2D concentrations [24, 25]. The decreased
25(OH)D concentration was probably due to heightened
circulating levels of 1,25(OH)2D which enhanced 25(OH)D
turnover into inactive metabolites [26, 27]. C-rPTH levelsInternational Journal of Endocrinology 7
Table 3: Analysis of rPTH HPLC proﬁles obtained by each rPTH assay.
Groups rPTH assay Pool value (pmol/L) Rec. (%) C-PTH fragments
(pmol/L) (%)
Non(1-84) PTH N-PTH PTH(1-84)
Normal-Ca diet Whole 3.6 117 0 (0.4) 0.3 (8.5) 3.3 (91.1)
Total 5.4 99 0.3 (5.8) 0.4 (8.2) 4.6 (86.0)
C9 . 0 9 7 4.2 (46.6) 0.5 (5.2) 0.2 (2.2) 4.1 (46.0)
Low-Ca diet Whole 7.6 111 0.2 (2.1) 0.5 (7.1) 6.9 (90.8)
Total 11.1 94 1.7 (15.6) 0.9 (8.3) 8.4 (76.1)
C 17.7 95 8.5 (48.3) 0.5 (2.8) 1.7 (9.6) 7.0 (39.3)
Vitamin D-deﬁcient diet Whole 25.5 108 0.4 (1.6) 1.5 (6.0) 23.6 (92.4)
Total 34.0 103 3.9 (11.4) 2.7 (7.9) 27.4 (80.7)
C 45.0 116 15.5 (34.5) 3.5 (7.7) 2.4 (5.3) 23.6 (52.5)
Moderate renal failure Whole 22.8 114 0.4 (1.9) 7.4 (32.6) 14.9 (65.5)
Total 15.0 108 1.3 (8.7) 3.5 (23.1) 10.2 (68.2)
C 43.2 100 18.9 (43.8) 0.5 (1.2) 11.1 (25.8) 12.6 (29.2)
Severe renal failure Whole 127.3 99 2.8 (2.2) 38.6 (30.3) 85.9 (67.5)
Total 122.0 83 5.7 (4.7) 24.6 (20.2) 91.6 (75.1)
C 278.0 107 157.9 (56.8) 0.0 (0.0) 45.0 (16.2) 75.1 (27.0)
Results of 1 HPLC proﬁle in each case.
rose more than T- and W-rPTH levels. More non-(1-84)
rPTH was found by T-rPTH assay, and C-rPTH fragments
by C-rPTH assay on HPLC proﬁles, a surprising observation
as a greater proportion of rPTH(1-84) might have been
expected [28]. An enhanced turnover of rPTH(1-84) into
non-(1-84) rPTH and C-rPTH fragments appears to be
responsible and may be ascribed to elevated 1,25(OH)2D
concentrations [3, 29]. Despite heightened 1,25(OH)2D
levels, rPTH concentrations increased but less than in -D
diet rats. This is likely the result of a partial inhibitory eﬀect
of calreticulin on 1,25(OH)2D binding to its receptor in
the parathyroid glands in the presence of hypocalcemia and
sHPT [30, 31].
A slightly diﬀerent situation prevailed in rats maintained
on a -D diet for 33 days. The calcium level was decreased
with normal phosphate concentration, normal alkaline
phosphatase activity, low 25(OH)D and 1,25(OH)2Dc o n -
centrations, elevated rPTH levels, and a high C/T-rPTH
ratio.Anegativecorrelationwasobservedbetween25(OH)D
and 1,25(OH)2D levels. Hypocalcemia was best explained
by reduced intestinal absorption of calcium induced by
low 1,25(OH)2D[ 32, 33]i nr e l a t i o nt ov e r yl o ws u b s t r a t e
concentrations [1]. The latter is probably the consequence
of deﬁcient vitamin D supply [1]. rPTH levels were elevated
becauseofhypocalcemiaandlow1,25(OH)2D,bothofwhich
stimulated rPTH production via diﬀerent mechanisms [34–
36]. C/T-rPTH rose because of greater C-rPTH than T-
rPTH increment possibly due to the catabolism of secreted
rPTH(1-84) into C-rPTH fragments. This diﬀers from our
dogmodelofDdeﬁciencywhere%PTH(1-84)wasincreased
[1, 28], but the latter study was of two-year duration.
A slightly longer study might have provided a calcemic
dissociation between -Ca and -D diets. In dogs after 3 weeks
of a -Ca -D diet, C-PTH fragments were also elevated (28).
In moderate RF, a 3-fold augmentation of serum cre-
atinine was observed with normal calcium level, normal
25(OH)D and low 1,25(OH)2D concentrations, increased
W- and C-rPTH levels, and a decreased T/W-rPTH ratio.
Two-thirds of the rPTH elevation was explained by rPTH(1-
84) and one-third by N-rPTH on W-rPTH assay. The % of
C-rPTH fragments was not enhanced in C-rPTH assay, but
this may be related to overevaluation of N-PTH associated
with the use of rPTH(39-84) standard. Low 1,25(OH)2D
levels linked with RF [37] contributed to the decrease
in intestinal calcium absorption [32, 33], while increased
rPTH(1-84) levels contributed to normal phosphate levels
[38]. Since W-rPTH increased more than T-rPTH, the T/W-
rPTH ratio declined mostly in relation to more N-rPTH
detected by W-rPTH assay. In more severe RF, rats had
impaired growth with lower body weight [39–41]. Serum
creatinine wasincreased by 8-fold, hypocalcemia was present
with normal phosphate levels, and alkaline phosphatase
activity was decreased, as were 25(OH)D and 1,25(OH)2D
levels, and W- and T-rPTH were augmented 30- and 20-
fold,respectively,withC-rPTHmorethan35-fold.TheT/W-
rPTH ratio was reduced and the C/T-rPTH ratio increased.
Hypocalcemia was best explained again by low intestinal
calcium absorption ascribed to low 1,25(OH)2D[ 32, 33].
The phosphate level was still normal because rPTH was
augmented, and RF was still not signiﬁcantly suﬃcient to
impair renal phosphate excretion [38], but the phosphate
level was more elevated than in moderate RF. The decrease
in alkaline phosphatase activity reﬂected the much lower
weight of these rats compared to the other groups, and
their impaired growth was related to advanced RF [39–
41]. Low 25(OH)D levels could not be linked to high
1,25(OH)2D levels in these rats. Decreased intestinal vitamin
Da b s o r p t i o n[ 42] in part related to their lower weight and8 International Journal of Endocrinology
eating proﬁle and reduced 25(OH)D production associated
with cytochrome P450 diminution in the liver by very high
rPTH levels [43] may have been responsible. As in rats
with milder RF, W-rPTH elevation was two-thirds related to
rPTH(1-84) and one-third to N-PTH. Accumulation of C-
rPTH fragments was observed with more advanced RF, as
in humans [9]. The decreased T/W-rPTH ratio is explained
by the same mechanism seen in moderate RF, while the
increased C/T-rPTH ratio is attributed to the accumulation
of C-rPTH fragments.
In summary, our results indicate that rPTH assays
with characteristics similar to those in hPTH assays are
useful tools to identify rPTH molecular forms similar to
those found in humans. Quantitative diﬀerences may exist
with humans in relation to more rPTH(1-84) and less C-
rPTH fragments in rats. In models of sHPT due to a -Ca
diet, a -D diet, or severe RF, we discerned low 25(OH)D
levels. If decreased vitamin D supply on the -D diet and
elevated 25(OH)D turnover induced by high 1,25(OH)2D
levels on the -Ca diet explain the low 25(OH)D level, they
could not explain the low 25(OH)D level in RF. Reduced
intestinal absorption of vitamin D [42] and diminished
hepatic 25(OH)D synthesis related to a direct eﬀect of severe
sHPT on cytochrome P450 level in the liver [43]m a yb e
implicated. More studies will be required to investigate these
mechanisms.
The behavior of rPTH molecular forms derived from
r P T Hr a t i o sw a sa se x p e c t e di ns e v e r eR Fw i t ht h ea c c u -
mulation of smaller C-rPTH fragments and an increase in
the C/T-rPTH ratio. This is believed to contribute to the
PTH resistance observed in renal failure experimentally (4–
7). Similarly, the increase in smaller C-rPTH fragments on
the -Ca diet was expected even if C/T and C/W-rPTH ratios
were not signiﬁcantly increase in relation with the very high
levelsof1,25(OH)2Dwhichwillinﬂuencethedegradationof
PTH(1-84) into fragments in the parathyroid glands (3, 29).
The only unexplained situation remains the increase in C-
rPTH fragments on the -D diet with the increase C/T-rPTH
ratio when one would have expected more rPTH(1-84) as in
a dog model (1). The short-time course of rat experiments
may be involved in these diﬀerences because on a -Ca -D diet
indogsasimilarproﬁlewasobservedat3weeks(28).Overall
this study demonstrates a behavior of rPTH molecular forms
similar to other species with minor diﬀerences related to the
shorter-time course of the study.
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